| abstract |
The subject of the present invention is a dosage form of a pharmaceutical formulation for treating a patient in the face of increased cardiovascular risk. The object is to combine as an active agent a cholesterol-lowering drug, a renin-angiotensin system inhibitor, aspirin, and optionally at least one of vitamins B6, B12 and folate, Oral, present in a unit dose suitable for once daily administration, wherein at least one of the active agents is contained in a dosage unit in a dosage form that is physically separated from it and the other active agent It was solved by providing an administrable pharmaceutical formulation. This formulation is provided as a simple and convenient therapy to reduce the risk of cardiovascular events in individuals facing increased cardiovascular risk, such as individuals with systemic lupus erythematosus. This formulation is also a therapeutic agent for individuals during or soon after the onset of acute myocardial infarction. [Selection figure] None |